Early-stage drug-discovery company creator that originates companies in-house, incubates single ultra-orphan and rare-disease bets for years and millions, and commits to very long development timelines.

Founded2007

Location

📍 Boston

🌍 USA

🌎 North America

Countries invested

💼 USA

Headquarters29 Newbury St., 3rd Floor, Boston, MA 02116, US

Investment offer

Check size$5,000,000 – $100,000,000

Can lead rounds

Details

Avg Check: $100K - $5M ·

Funding requirements

We invest in therapeutics. We are a venture studio focused on company formation that translates bleeding-edge science into medicines that transform patient lives.

Numbers

Total Investments

123

Total Exits